Ether

Ether

SCHEMBL1492008

CC(=O)O.CCO.CCOCC

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Ether. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.46
TSHR P16473 3/20 0.46
FFAR3 O14843 2/20 0.44
LCK P06239 1/20 0.44
FYN P06241 1/20 0.44
LMNA P02545 1/20 0.43
HSD17B10 Q99714 1/20 0.43
THRB P10828 1/20 0.39
TDP1 Q9NUW8 1/20 0.37
THPO P40225 1/20 0.35
ALOX15 P16050 1/20 0.35
MGAM O43451 1/20 0.35
GAA P10253 1/20 0.35
SI P14410 1/20 0.35
MGAM2 Q2M2H8 1/20 0.35
SOAT1 P35610 1/20 0.35
HCAR2 Q8TDS4 1/20 0.33
KDM4E B2RXH2 1/20 0.32
PKM P14618 1/20 0.32
GLA P06280 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzene SCHEMBL8432661 0.94 ALDH1A1 (0.42) ALDH1A1TSHRFFAR3LCKFYN
Ether SCHEMBL28393262 0.94 ALDH1A1 (0.50) ALDH1A1TSHRFFAR3LCKFYN
Ether SCHEMBL7115101 0.94 ALDH1A1 (0.50) ALDH1A1TSHRFFAR3LCKFYN
Ether SCHEMBL20338904 0.94 ALDH1A1 (0.50) ALDH1A1TSHRFFAR3LCKFYN
Ether SCHEMBL115545 0.94
Ether SCHEMBL28328411 0.94 ALDH1A1 (0.50) ALDH1A1TSHRFFAR3LCKFYN
Ether SCHEMBL271068 0.91 ALDH1A1 (0.48) ALDH1A1TSHRFFAR3LCKFYN
Ether SCHEMBL151167 0.91 ALDH1A1 (0.48) ALDH1A1TSHRFFAR3LCKFYN
Ether SCHEMBL11311472 0.90 ALDH1A1 (0.48) ALDH1A1TSHRFFAR3LCKFYN
Ether SCHEMBL17766472 0.90 ALDH1A1 (0.48) ALDH1A1TSHRFFAR3LCKFYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240034828-A1 Aqueous Polyurethane Urea Dispersion COVESTRO DEUTSCHLAND AG (DE) 2024-02-01 US disclosed
EP-4259683-A1 AQUEOUS POLYURETHANE UREA DISPERSION Covestro Deutschland AG (DE) 2023-10-18 EP disclosed
CN-116601201-A Aqueous polyurethane urea dispersions 科思创德国股份有限公司 2023-08-15 CN disclosed
EP-4029894-A1 AQUEOUS POLYURETHANE UREA DISPERSION Covestro Deutschland AG (DE) 2022-07-20 EP disclosed
WO-2022122567-A1 AQUEOUS POLYURETHANE UREA DISPERSION COVESTRO DEUTSCHLAND AG (DE) 2022-06-16 WO disclosed
CN-114605611-A Aqueous polyurethane urea dispersions 科思创德国股份有限公司 2022-06-10 CN disclosed
CN-104357951-A Cotton fiber for heat-insulating and sound-absorbing materials for buildings and producing method of cotton fiber ANHUI YINGYUAN AGRICULTURAL TECHNOLOGY CO LTD 2015-02-18 CN disclosed
CN-102964967-A Anticorrosive coating Qingdao xuanwei coating material co ltd 2013-03-13 CN disclosed
US-8034122-B2 Bleaching agent comprising 2-acylpyridinium derivatives HENKEL AG & CO. KGAA (DE) 2011-10-11 US disclosed
US-7981166-B2 Bleaching agent having cationic acyl pyridinium derivatives, co-bleaching activators and hydrogen peroxide HENKEL AG & CO. KGAA (DE) 2011-07-19 US disclosed
US-20110162671-A1 BLEACHING AGENT COMPRISING 2-ACYLPYRIDINIUM DERIVATIVES HENKEL AG & CO. KGAA (DE) 2011-07-07 US disclosed
US-20110047712-A1 BLEACHING AGENT HAVING CATIONIC ACYL PYRIDINIUM DERATIVES, CO-BLEACHING ACTIVATORS AND HYDROGEN PEROXIDE HENKEL AG & CO. KGAA (DE) 2011-03-03 US disclosed
CN-1079283-C Load type laminated zirconium sulfate catalyst and its application in preparation of aliphatic alcohol ether acetate BEIJING UNIV OF CHEMICAL ENGIN (CN) 2002-02-20 CN disclosed
EP-1015033-A2 SUBSTITUTED PERYLENEQUINONES FOR USE IN PHOTODYNAMIC THERAPY AltaRex, Corp. (CA) 2000-07-05 EP disclosed
EP-1015033-A4 SUBSTITUTED PERYLENEQUINONES FOR USE IN PHOTODYNAMIC THERAPY ALTAREX INC (CA) 2000-07-05 EP disclosed
CN-1253856-A Load type laminated zirconium sulfate catalyst and its application in preparation of aliphatic alcohol ether acetate BEIJING UNIV OF CHEMICAL ENGIN (CN) 2000-05-24 CN disclosed
WO-1998033470-A2 SUBSTITUTED PERYLENEQUINONES FOR USE IN PHOTODYNAMIC THERAPY ALTAREX CORP. (CA) 1998-08-06 WO disclosed
CN-1043177-A Carry out the method for dyeing keratinous fibres and new 1,4-benzoquinones with oxyindole and quinone derivative OREAL (FR) 1990-06-20 CN disclosed
US-4556744-A Process for the production of ethanol and/or acetaldehyde by the metal catalysed liquid phase reaction of methanol, carbon monoxide and hydrogen in the presence of a solvent THE BRITISH PETROLEUM COMPANY P.L.C. (GB) 1985-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110047712-A1 BLEACHING AGENT HAVING CATIONIC ACYL PYRIDINIUM DERATIVES, CO-BLEACHING ACTIVATORS AND HYDROGEN PEROXIDE F12, KRT18, H1-3 ALDH1A1 980/4885TSHR 2090/4885FFAR3 648/4885
US-20110162671-A1 BLEACHING AGENT COMPRISING 2-ACYLPYRIDINIUM DERIVATIVES KRT18, CBR3, ACOX3 ALDH1A1 401/4885TSHR 2327/4885FFAR3 283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.